Imaging the microvessel caliber and density: Principles and applications of microvascular MRI

Magnetic Resonance in Medicine

Volumn 73, Issue 1, 2015, Pages 325-341

  Troprès, Irène ^a,b,c,d,e,f   Pannetier, Nicolas ^e,f   Grand, Sylvie ^d,e,f   Lemasson, Benjamin ^e,f   Moisan, Anaïck ^e,f   Péoc'h, Michel ^g,h   Rémy, Chantal ^e,f   Barbier, Emmanuel L ^e,f  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CNRS   (France)

^c INSERM   (France)

^d HÔPITAL MICHALLON   (France)

^e UNIV GRENOBLE ALPES   (France)

^f GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h Jean Monnet University   (France)

Author keywords

Angiogenesis; Capillary; Mean vessel diameter; Perfusion; Vessel density; Vessel size index

Indexed keywords

BLOOD VESSELS; NUCLEAR MAGNETIC RESONANCE;

ANGIOGENESIS; CAPILLARY; PERFUSION; VESSEL DIAMETER; VESSEL SIZE INDICES;

MAGNETIC RESONANCE IMAGING;

ARTICLE; BLOOD VOLUME; DENSITY; MAGNETIC FIELD; MAGNETISM; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; SIMULATION; STEADY STATE; VALIDATION STUDY; ALGORITHM; ANATOMY AND HISTOLOGY; COMPUTER ASSISTED DIAGNOSIS; DENSITOMETRY; HUMAN; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; DENSITOMETRY; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MICROVESSELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84919832002     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25396     Document Type: Article

References (98)

1. Oostendorp M, Post MJ, Backes WH. Vessel growth and function: depiction with contrast-enhanced MR imaging. Radiology 2009;251:317-335.
2. Pathak AP. Magnetic resonance susceptibility based perfusion imaging of tumors using iron oxide nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;1:84-97.
3. Seevinck P, Deddens L, Dijkhuizen R. Magnetic resonance imaging of brain angiogenesis after stroke. Angiogenesis 2010;13:101-111.
4. Passe TJ, Bluemke DA, Siegelman SS. Tumor angiogenesis: tutorial on implications for imaging. Radiology 1997;203:593-600.
5. Padhani AR, Neeman M. Challenges for imaging angiogenesis. Br J Radiol 2001;74:886-890.
6. Miles KA. Functional computed tomography in oncology. Eur J Cancer 2002;38:2079-2084.
7. Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. [Miscellaneous Article]. Curr Opin Neurol 2008;21:728-735.
8. Missbach-Guentner J, Hunia J, Alves F. Tumor blood vessel visualization. Int J Dev Biol 2011;55:535-546.
9. Thompson G, Mills SJ, Coope DJ, O'Connor JPB, Jackson A. Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. Br J Radiol 2012;84:S127-S144.
10. García-Figueiras R, Goh VJ, Padhani AR, Baleato-González S, Garrido M, León L, Gómez-Caamaño A. CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 2013;200:8-19.
11. Kleibeuker EA, Griffioen AW, Verheul HM, Slotman BJ, Thijssen VL. Combining angiogenesis inhibition and radiotherapy: a double-edged sword. Drug Resist Updat 2012;15:173-182.
12. Russo G, Mischi M, Scheepens W, De la Rosette JJ, Wijkstra H. Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int 2012;110:E794-E808.
13. Chang Y-W, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, Yang SB, Kim Y, Seo DY. Magnetic resonance imaging of breast cancer and correlation with prognostic factors. Acta Radiol 2009;50:990-998.
14. Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One 2012;7:e36893.
15. Rigau V, Morin M, Rousset M-C, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007;130:1942-1956.
16. Willats L, Calamante F. The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI. NMR Biomed 2013;26:913-931.
17. Barbier EL, Lamalle L, Décorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001;13:496-520.
18. Bereczki D, Wei L, Acuff V, Gruber K, Tajima A, Patlak C, Fenstermacher J. Technique-dependent variations in cerebral microvessel blood volumes and hematocrits in the rat. J Appl Physiol (1985) 1992;73:918-924.
19. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
20. Huang W, Li X, Morris EA, Tudorica LA, Seshan VE, Rooney WD, Tagge I, Wang Y, Xu J, Springer CS. The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci USA 2008;105:17943-17948.
21. Kennan RP, Zhong J, Gore JC. On the relative importance of paramagnetic relaxation and diffusion-mediated susceptibility losses in tissues. Magn Reson Med 1991;22:197-203; discussion 213-215.
22. Boxerman JL, Bandettini PA, Kwong KK, Baker JR, Davis TL, Rosen BR, Weisskoff RM. The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med 1995;34:4-10.
23. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749-763.
24. Kiselev VG, Posse S. Analytical model of susceptibility-induced MR signal dephasing: effect of diffusion in a microvascular network. Magn Reson Med 1999;41:499-509.
25. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 2001;46:1113-1122.
26. Jensen JH, Chandra R. Strong field behavior of the NMR signal from magnetically heterogeneous tissues. Magn Reson Med 2000;43:226-236.
27. ∗2 in the capillary network of myocardium. Magn Reson Med 1999;41:51-62.
28. Kennan RP, Gao JH, Zhong J, Gore JC. A general model of microcirculatory blood flow effects in gradient sensitized MRI. Med Phys 1994;21:539-545.
29. Kiselev VG, Posse S. Analytical theory of susceptibility induced NMR signal dephasing in a cerebrovascular network. Phys Rev Lett 1998;81:5696-5699.
30. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Décorps M. Vessel size imaging. Magn Reson Med 2001;45:397-408.
31. Pannetier NA, Debacker CS, Mauconduit F, Christen T, Barbier EL. A simulation tool for dynamic contrast enhanced MRI. PLoS One 2013;8:e57636.
32. ∗: a numerical study of the impact of model assumptions. Magn Reson Med 2012;67:1458-1468.
33. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, Rosen BR, Brady TJ. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-347.
34. Le Duc G, Péoc'h M, Rémy C, Charpy O, Muller RN, Le Bas JF, Décorps M. Use of T2-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn Reson Med 1999;42:754-761.
35. Lin C-Y, Chang C, Cheung W-M, Lin M-H, Chen J-J, Hsu CY, Chen JH, Lin T-N. Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrast-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab 2008;28:1491-1501.
36. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
37. Farrar CT, Kamoun WS, Ley CD, Kim YR, Catana C, Kwon SJ, Rosen BR, Jain RK, Sorensen AG. Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model. PLoS One 2011;6:e17228.
38. Wu EX, Tang H, Jensen JH. High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q. NMR Biomed 2004;17:507-512.
39. Farrar CT, Kamoun WS, Ley CD, Kim YR, Kwon SJ, Dai G, Rosen BR, Tomaso E di, Jain RK, Sorensen AG. In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model. Neuro Oncol 2010;12:341-350.
40. Lemasson B, Valable S, Farion R, Krainik A, Rémy C, Barbier EL. In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology. Magn Reson Med 2013;69:18-26.
41. Kiselev VG, Strecker R, Ziyeh S, Speck O, Hennig J. Vessel size imaging in humans. Magn Reson Med 2005;53:553-563.
42. Troprès I, Lamalle L, Péoc'h M, Farion R, Usson Y, Décorps M, Rémy C. In vivo assessment of tumoral angiogenesis. Magn Reson Med 2004;51:533-541.
43. Pannetier NA, Sohlin M, Christen T, Schad L, Schuff N. Numerical modeling of susceptibility-related MR signal dephasing with vessel size measurement: phantom validation at 3T. Magn Reson Med 2014;72:646-658.
44. Boehm-Sturm P, Farr TD, Adamczak J, Jikeli JF, Mengler L, Wiedermann D, Kallur T, Kiselev V, Hoehn M. Vascular changes after stroke in the rat: a longitudinal study using optimized magnetic resonance imaging. Contrast Media Mol Imaging 2013;8:383-392.
45. ∗ quantification. Magn Reson Med 2011;66:144-153.
46. Batchelor TT, Sorensen AG, di Tomaso E, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007;11:83-95.
47. Shen Y, Pu IM, Ahearn T, Clemence M, Schwarzbauer C. Quantification of venous vessel size in human brain in response to hypercapnia and hyperoxia using magnetic resonance imaging. Magn Reson Med 2013;69:1541-1552.
48. Schmiedeskamp H, Straka M, Newbould RD, Zaharchuk G, Andre JB, Olivot J-M, Moseley ME, Albers GW, Bammer R. Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med 2012;68:30-40.
49. Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Baddrudoja MA, Krouwer HGJ. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524-1532.
50. Jensen JH, Lu H, Inglese M. Microvessel density estimation in the human brain by means of dynamic contrast-enhanced echo-planar imaging. Magn Reson Med 2006;56:1145-1150.
51. Quarles CC, Schmainda KM. Assessment of the morphological and functional effects of the anti-Angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI. Magn Reson Med 2007;57:680-687.
52. Pannetier N, Lemasson B, Christen T, Tachrount M, Troprès I, Farion R, Segebarth C, Rémy C, Barbier EL. Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches. NMR Biomed 2012;25:218-226.
53. Xu C, Schmidt WUH, Villringer K, Brunecker P, Kiselev V, Gall P, Fiebach JB. Vessel size imaging reveals pathological changes of microvessel density and size in acute ischemia. J Cereb Blood Flow Metab 2011;31:1687-1695.
54. Xu C, Schmidt WUH, Galinovic I, Villringer K, Hotter B, Ostwaldt AC, Denisova N, Kellner E, Kiselev V, Fiebach JB. The potential of microvessel density in prediction of infarct growth: a two-month experimental study in vessel size imaging. Cerebrovasc Dis 2012;33:303-309.
55. Xu C, Kiselev VG, Möller HE, Fiebach JB. Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging. Magn Reson Med 2013;69:981-991.
56. Donahue KM, Krouwer HGJ, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW. Utility of simultaneously acquired gradientecho and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845-853.
57. ∗-dominant extravasation correction in DSC-MRI. I-theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011;31:2041-2053.
58. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C, Barbier EL. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 2008;21:1043-1056.
59. Beaumont M, Lemasson B, Farion R, Segebarth C, Rémy C, Barbier EL. Characterization of tumor angiogenesis in rat brain using ironbased vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab 2009;29:1714-1726.
60. Sedlacik J, Rauscher A, Reichenbach JR. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn Reson Med 2007;58:1035-1044.
61. Lemasson B, Christen T, Tizon X, et al. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and antiangiogenic drug effects. NMR Biomed 2011;24:473-482.
62. Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, Carano RAD. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 2011;65:889-899.
63. Sampath D, Oeh J, Wyatt SK, et al. Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response. Neoplasia 2013;15:694-711.
64. Walker-Samuel S, Boult JKR, McPhail LD, Box G, Eccles SA, Robinson SP. Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. Int J Cancer 2012;130:1284-1293.
65. Serduc R, Christen T, Laissue J, et al. Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study. Phys Med Biol 2008;53:3609.
66. Bouchet A, Lemasson B, Le Duc G, et al. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks. Int J Radiat Oncol 2010;78:1503-1512.
67. Coquery N, Pannetier N, Farion R, et al. Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma. PLoS One 2012;7:e40567.
68. Bosomtwi A, Jiang Q, Ding GL, Zhang L, Zhang ZG, Lu M, Ewing JR, Chopp M. Quantitative evaluation of microvascular density after stroke in rats using MRI. J Cereb Blood Flow Metab 2008;28:1978-1987.
69. Moisan A, Pannetier N, Grillon E, Richard M-J, de Fraipont F, Rémy C, Barbier EL, Detante O. Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study. NMR Biomed 2012;25:1340-1348.
70. Jochimsen TH, Möller HE. Increasing specificity in functional magnetic resonance imaging by estimation of vessel size based on changes in blood oxygenation. Neuroimage 2008;40:228-236.
71. Jochimsen TH, Ivanov D, Ott DVM, Heinke W, Turner R, Möller HE, Reichenbach JR. Whole-brain mapping of venous vessel size in humans using the hypercapnia-induced BOLD effect. Neuroimage 2010;51:765-774.
72. Dickson JD, Ash TWJ, Williams GB, Sukstanskii AL, Ansorge RE, Yablonskiy DA. Quantitative phenomenological model of the BOLD contrast mechanism. J Magn Reson 2011;212:17-25.
73. Kim E, Cebulla J, Douglas Ward B, Rhie K, Zhang J, Pathak AP. Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant? Magn Reson Med 2013;70:1106-1116.
74. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 2010;14:1241-1254.
75. Biron KE, Dickstein DL, Gopaul R, Jefferies WA. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 2011;6:e23789.
76. Beaumont M, DuVal MG, Loai Y, Farhat WA, Sándor GK, Cheng HLM. Monitoring angiogenesis in soft-tissue engineered constructs for calvarium bone regeneration: an in vivo longitudinal DCE-MRI study. NMR Biomed 2010;23:48-55.
77. ∗ for improved specificity. NMR Biomed 2012;25:418-426.
78. Packard SD, Mandeville JB, Ichikawa T, Ikeda K, Terada K, Niloff S, Chiocca EA, Rosen BR, Marota JJA. Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI. Neoplasia 2003;5:330-338.
79. Badruddoja MA, Krouwer HGJ, Rand SD, Rebro KJ, Pathak AP, Schmainda KM. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 2003;5:235-243.
80. Ullrich RT, Jikeli JF, Diedenhofen M, Böhm-Sturm P, Unruh M, Vollmar S, Hoehn M. In-vivo visualization of tumor microvessel density and response to anti-Angiogenic treatment by high resolution MRI in mice. PLoS One 2011;6:e19592.
81. Douma K, Oostendorp M, Slaaf DW, Post MJ, Backes WH, van Zandvoort MAMJ. Evaluation of magnetic resonance vessel size imaging by two-photon laser scanning microscopy. Magn Reson Med 2010;63:930-939.
82. Bosomtwi A, Chopp M, Zhang L, Zhang ZG, Lu M, Jiang Q. Mean microvessel segment length and radius after embolic stroke: comparison of magnetic resonance imaging (MRI) and laser scanning confocal microscopy (LSCM). Brain Res 2011;1381:217-227.
83. Burrell JS, Bradley RS, Walker-Samuel S, Jamin Y, Baker LCJ, Boult JKR, Withers PJ, Halliday J, Waterton JC, Robinson SP. MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting. Microvasc Res 2012;84:323-329.
84. Persigehl T, Ring J, Budny T, Hahnenkamp A, Stoeppeler S, Schwartz LH, Spiegel H-U, Heindel W, Remmele S, Bremer C. Vessel size imaging (VSI) by robust magnetic resonance (MR) relaxometry: MR-VSI of solid tumors in correlation with immunohistology and intravital microscopy. Mol Imaging 2013;12:1-11.
85. Kostourou V, Robinson SP, Whitley GSJ, Griffiths JR. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res 2003;63:4960-4966.
86. Howe FA, McPhail LD, Griffiths JR, McIntyre DJO, Robinson SP. Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model. Int J Radiat Oncol 2008;71:1470-1476.
87. Robinson SP, Ludwig C, Paulsson J, östman A. The effects of tumorderived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI. Int J Cancer 2008;122:1548-1556.
88. Zwick S, Strecker R, Kiselev V, et al. Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging. J Magn Reson Imaging 2009;29:1125-1133.
89. Woenne EC, Lederle W, Zwick S, Palmowski M, Krell H, Semmler W, Mueller MM, Kiessling F. MMP Inhibition Blocks Fibroblastdependent Skin Cancer Invasion, Reduces Vascularization and Alters VEGF-A and PDGF-BB Expression. Anticancer Res 2010;30:703-711.
90. Yuan A, Lin C-Y, Chou C-H, et al. Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI. PLoS One 2011;6:e16062.
91. Bäuerle T, Merz M, Komljenovic D, Zwick S, Semmler W. Druginduced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study. Clin Cancer Res 2010;16:3215-3225.
92. Merz M, Komljenovic D, Zwick S, Semmler W, Bäuerle T. Sorafenib tosylate and paclitaxel induce anti-Angiogenic, anti-tumour and antiresorptive effects in experimental breast cancer bone metastases. Eur J Cancer 2011;47:277-286.
93. Nielsen T, Bentzen L, Pedersen M, Tramm T, Rijken PFJW, Bussink J, Horsman MR, Østergaard L. Combretastatin A-4 phosphate affects tumor vessel volume and size distribution as assessed using MRIbased vessel size imaging. Clin Cancer Res 2012;18:6469-6477.
94. Wade TP, Kozlowski P. Longitudinal studies of angiogenesis in hormone-dependent shionogi tumors. Neoplasia 2007;9:563-568.
95. Ferretti S, Allegrini PR, O'Reilly T, Schnell C, Stumm M, Wartmann M, Wood J, McSheehy PMJ. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Clin Cancer Res 2005;11:7773-7784.
96. Weidensteiner C, Metzger F, Bohrmann ABB, Kuennecke B, von Kienlin M. Cortical hypoperfusion in the B6. PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI. Magn Reson Med 2009;62:35-45.
97. Lu J, Dai G, Egi Y, Huang S, Kwon SJ, Lo EH, Kim YR. Characterization of cerebrovascular responses to hyperoxia and hypercapnia using MRI in rat. Neuroimage 2009;45:1126-1134.
98. Skinner JT, Robison RK, Quarles CC. A single-shot multiple spinand gradient-echo acquisition for perfusion imaging using SENSE acceleration and partial k-space sampling. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. Abstract 2196.